Alpine Immune Sciences, Inc. vs DBV Technologies

Alpine Immune Sciences, Inc. logo

Alpine Immune Sciences, Inc.

Leading the Next Evolution of Immunotherapies

99 employees · est. 2015 · Seattle, United States

VS
DBV Technologies logo

DBV Technologies

On a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™

187 employees · est. 2002 · Chatillon, France

DBV Technologies is the older company (2015 vs 2002).

Side-by-Side Comparison

Alpine Immune Sciences, Inc. DBV Technologies
Founded
2015 2002 older
Headquarters
Seattle, United States Chatillon, France
Employees
99 187
Industry
Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Post-IPO Equity Post-IPO Equity
Total Funding
$475.30M $239.80M
Funding Rounds
7 7
Services
Not tracked yet Development and clinical trials of epicutaneous immunotherapy for food allergies and immunological diseases
Target Customers
Not tracked yet Patients with food allergies and other immunological diseases, healthcare providers, investors
Taxonomy
Clinical-stage BiopharmaceuticalImmunotherapyAutoimmune DiseasesInflammatory DiseasesProtein-based TherapiesImmune Synapse Targeting +9 Epicutaneous ImmunotherapyViaskin TechnologyBiopharmaceutical ResearchTreatment DevelopmentImmunologic DiseasesPediatric Allergies +5
Website
alpineimmunesciences.com dbv-technologies.com
Alpine Immune Sciences, Inc. logo

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is a leading player in the biotechnology and health care industries. Founded in 2015, the company has now become a part of Vertex Pharmaceuticals, a global biotechnology company with a focus on transformative medicines for individuals with serious diseases. Alpine Immune...

DBV Technologies logo

About DBV Technologies

DBV Technologies is a global clinical stage biopharmaceutical company founded in 2002 by pediatricians who envisioned the safe and effective treatment of food allergies. The company is headquartered in France and is dedicated to advancing epicutaneous immunotherapy using their innovative technology...

Also comparing in this category

Comparing more than these two?

Get Alpine Immune Sciences, Inc., DBV Technologies and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Alpine Immune Sciences, Inc. compare?

A PDF of Alpine Immune Sciences, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Alpine Immune Sciences, Inc. was founded in 2015, based in Seattle, United States, with 99 employees. Alpine Immune Sciences, Inc. is a leading player in the biotechnology and health care industries. Founded in 2015, the company has now become a part of Vertex Pharmaceuticals, a global biotechnology c. DBV Technologies was founded in 2002, based in Chatillon, France, with 187 employees. DBV Technologies is a global clinical stage biopharmaceutical company founded in 2002 by pediatricians who envisioned the safe and effective treatment of food allergies. The company is headquartered i.
Alpine Immune Sciences, Inc. has raised $475.30M and DBV Technologies $239.80M. Latest stage: Alpine Immune Sciences, Inc. Post-IPO Equity, DBV Technologies Post-IPO Equity.
Both work in Biotechnology and Health Care.

Compare Alpine Immune Sciences, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Alpine Immune Sciences, Inc. on 11 Sep 2024, and DBV Technologies on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes